Supplementary Table S1 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Table S1. Participating institutions for all patients (N=345) and patients presenting with anemia(N=54).</p

Supplementary Table S2 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Table S2. Eligibility criteria.</p

Supplementary Table S3 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Table S3. Treatment delivery for all patients (N=345) and the patients presenting with anemia (N=54).</p

CCR Translation for This Article from CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

CCR Translation for This Article from CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cance

Supplementary Tables 1 - 4, Figures 1 - 4 from CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

PDF file - 224K</p